Therapure Biopharma has opened its Custom Biologics Manufacturing Wing to support the development and manufacture of biologics. The facility offers advanced bioprotein production capabilities and the company expects to create as many as 100 jobs at the new facility.
 
“Therapure is thrilled to officially celebrate the opening of its additional Custom Biologics Manufacturing Wing, which will enhance the company’s ability to be an international leader in biomanufacturing and meet the needs of a growing market,” said Nick Green, president and chief executive officer of Therapure. “We are a proud member of Ontario’s life sciences community, and we look forward to contributing to growth and innovation in the region.”